SNPS vs STRO
Synopsys Inc (SNPS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SNPS currently screens at market cap $85.14B and trailing P/E 63.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SNPS and STRO stock pages for the full models.
Not investment advice.